Human HER2-targeted CAR-M cells therapy (Macera therapeutics)

N/A

Report date: 2024/12/20 16:03:59

Base Information

Drug NameHuman HER2-targeted CAR-M cells therapy (Macera therapeutics)
Drug Alias NameAnti-HER2 CAR-M cells therapy(Macera therapeutics)Human HER2-targeted Macrophages Therapy(Macera therapeutics)Human HER2-targeted Chimeric Antigen Receptor Macrophages Therapy(Macera therapeutics)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 modulatorsCell replacements
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNanjing Yuanmai Cell Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Yuanmai Cell Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsStomach Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A